Cargando…
Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment
The objective of this study was to evaluate the role of activated protein C (aPC), known to be a physiological anticoagulant, in ovarian cancer cell activation as well as in loss of clotting of cancer ascitic fluid. The effect of aPC on an ovarian cancer cell line (OVCAR-3) was tested in regards to...
Autores principales: | ALTHAWADI, HAMDA, ALFARSI, HALEMA, BESBES, SAMAHER, MIRSHAHI, SHAHSOLTAN, DUCROS, ELODIE, RAFII, ARASH, POCARD, MARC, THERWATH, AMU, SORIA, JEANNETTE, MIRSHAHI, MASSOUD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487670/ https://www.ncbi.nlm.nih.gov/pubmed/26082331 http://dx.doi.org/10.3892/or.2015.4061 |
Ejemplares similares
-
Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset
por: DUCROS, ELODIE, et al.
Publicado: (2012) -
Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells
por: AZZAZENE, DALEL, et al.
Publicado: ( 201) -
Thrombopoietin Secretion by Human Ovarian Cancer Cells
por: Besbes, Samaher, et al.
Publicado: (2017) -
Hospicells promote upregulation of the ATP-binding cassette genes by insulin-like growth factor-I via the JAK2/STAT3 signaling pathway in an ovarian cancer cell line
por: BENABBOU, NADIA, et al.
Publicado: (2013) -
Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies
por: Ducros, Elodie, et al.
Publicado: (2012)